Статья 19«Конвенция против применения допинга» (ETS № 135) [рус., англ.]
Актуально на 07.11.2026.
Как цитировать: Статья 19. "Конвенция против применения допинга" (ETS N 135) [рус., англ.]. 135. https://bukva.ai/docs/konventsiya-135-se-sovet-evropy/statya-19
Генеральный секретарь Совета Европы уведомляет Стороны, другие государства-члены Совета Европы, другие государства-участники Европейской культурной конвенции, государства, участвовавшие в разработке настоящей Конвенции, и любое государство, присоединившееся к ней либо получившее предложение о присоединении к ней, о нижеследующем:
a) любом подписании в соответствии со статьей 14;
b) передаче любого документа о ратификации, принятии, одобрении или присоединении в соответствии со статьями 14 или 16;
c) любой дате вступления в силу настоящей Конвенции в соответствии со статьями 15 и 16;
d) любой информации, переданной в соответствии с положениями статьи 9;
е) любом докладе, подготовленном на основании положений статьи 12;
f) любом предложении о поправке и о любой поправке, принятой в соответствии со статьей 13, и о дате вступления в силу этой поправки;
g) любом заявлении, сделанном на основании положений статьи 17;
h) любом уведомлении, направленном в соответствии с положениями статьи 18, и о дате вступления в силу денонсации;
i) любом другом акте, уведомлении или сообщении, относящихся к настоящей Конвенции.
В удостоверение чего нижеподписавшиеся, должным образом уполномоченные в этой связи, подписали настоящую Конвенцию.
Совершено в Страсбурге 16 ноября 1989 года на французском и английском языках в одном экземпляре, который сдается в архивы Совета Европы, причем оба текста имеют одинаковую силу. Генеральный секретарь Совета Европы передаст соответствующую заверенную копию каждому государству-члену Совета Европы, другим государствам-участникам Европейской культурной конвенции, государствам, не являющимся членами, участвовавшим в разработке настоящей Конвенции, и любому государству, которому предложено присоединиться к ней.
ПЕРЕЧЕНЬ КЛАССОВ ЗАПРЕЩЕННЫХ ВЕЩЕСТВ И ЗАПРЕЩЕННЫХ МЕТОДОВ <*>
E. Пептидные и гликопротеиновые гормоны и их аналоги
<*> По состоянию на 15 марта 1998 г. Приложение регулярно пересматривается Группой по рассмотрению действия (мониторинговой) на основе антидопингового списка Международного олимпийского комитета (предыдущие поправки вносились 1 сентября 1990 г., 24 января 1992 г., 1 августа 1993 г., 1 июля 1996 г., 1 июля 1997 г.).
B. Фармацевтические, химические и / или физические манипуляции
C. Местные анестезирующие средства
Запрещенные вещества разделяются на следующие классы:
E. Пептидные и гликопротеиновые гормоны и их аналоги
Не допускается применение любых веществ, относящихся к запрещенным классам, даже если они не указаны в качестве примера. Исходя из этого, вводится понятие «относящиеся к этому классу вещества». Под ними понимаются вещества, относящиеся к тому или иному классу по своим фармакологическим свойствам и / или химическому строению.
Примеры запрещенных веществ класса (A): аминептин, амифеназол, амфетамин, бромантан, карфедон, кокаин, кофеин <*>, мезокарб, пентилентетразол, пипрадол, салбутамол <**>, салметерол <>, тербуталин <>, фенкамфамин, эфедрин <***> и относящиеся к этому классу вещества.
<*> Для кофеина положительный результат зависит от его концентрации в моче. Концентрация не должна превышать 12 микрограмм на миллилитр.
<**> Вещество разрешено применять только путем ингаляции, о чем должно быть заявлено заблаговременно врачом команды или пульмонологом в письменной форме компетентному медицинскому органу.
<***> Для эфедрина, катина и метилэфедрина результат считается положительным, если концентрация в моче этих веществ составляет 5 микрограмм на миллилитр; для фенилпропаноламина и псевдоэфедрина — 10 микрограмм на миллилитр. Если присутствуют два и более из этих веществ, показатели их концентрации арифметически складываются, и результат считается положительным, если сумма концентраций превышает 10 микрограмм на миллилитр.
Примечание. Все препараты на основе производных имидазола могут быть использованы для местного применения, например, оксиметазолин. Сосудосуживающие средства (например, адреналин) могут применяться совместно с местными анестезирующими средствами. Разрешено применение препаратов фенилэфрина местного воздействия (например, носовые, офтальмологические).
Примеры запрещенных веществ класса (B): декстроморамид, диаморфин (героин), метадон, морфин, пентазоцин, петидин и относящиеся к этому классу вещества.
Примечание. Разрешены для применения: декстрометорфан, декстропропоксифен, дигидрокодеин, дифеноксилат, кодеин, пропоксифен, фолкодин, этилморфин.
Класс анаболических веществ включает:
Примеры запрещенных веществ класса (C):
1. Андрогенные анаболические стероиды (AAC):
андростенедион, дегидроэпиандростерон (DHEA), клостебол, метандиенон, метенолон, нандролон, оксандролон, станозолол, тестостерон <*>, флуоксиместерон и относящиеся к этому классу вещества.
<*> Если соотношение содержащихся в моче тестостерона (T/эпитестостерона (E) превышает «6», это является нарушением, за исключением случая, когда очевидно, что это соотношение обусловлено физиологическим состоянием или патологией, например, низкой экскрецией эпитестостерона, образованием андрогенных веществ в результате опухоли или недостатком энзимов.
В случае, если соотношение T/E превысило «6», для признания результата положительным должно быть проведено исследование компетентным медицинским органом. По его результатам составляется подробный отчет, который включает результаты предыдущих и последующих тестов, в том числе эндокринных исследований. Если результаты предыдущих анализов отсутствуют, спортсмен должен будет пройти контрольные тесты без предварительного оповещения минимум раз в месяц в течение трех месяцев. Результаты этих тестов будут включены в отчет. В случае отказа спортсмена от прохождения контрольных тестов результат будет признан положительным.
При систематическом применении бета-2 агонисты могут иметь сильное анаболизирующее действие.
Кленбутерол, салбутамол, салметерол, тербуталин, фенотерол и относящиеся к этому классу вещества.
Примеры запрещенных веществ класса (D): ацетазоламид, буметанид, гидрохлортиазид, маннитол <*>, мерсалил, спиронолактон, триамтерен, фуросемид, хлорталидон, этакриновая кислота и относящиеся к этому классу вещества.
<*> Запрещен для внутривенного введения.
E. Пептидные и гликопротеиновые гормоны и их аналоги
Примеры запрещенных веществ класса (E):
1. Хорионический гонадотропин (hCG — хорионический гонадотропин человека).
3. Гормон роста (hGH, соматотропин). Все вещества и их аналоги, стимулирующие выработку вышеперечисленных гормонов, также запрещены.
Запрещены следующие процедуры:
Кровяной допинг представляет собой введение спортсмену крови, красных кровяных клеток или родственных продуктов крови. Этому может предшествовать взятие у спортсмена крови, после чего он продолжает тренироваться в таком состоянии.
Фармацевтические, химические или физические манипуляции
Фармацевтические, химические или физические манипуляции означают использование веществ и методов, которые нарушают, применяются с целью нарушения или подвергают риску нарушить целостность и пригодность образцов мочи для проведения антидопингового контроля, например, применение катетеров, замена и / или фальсификация образцов, искусственное задерживание почечных выделений, в частности при помощи пробенецида или подобных веществ, изменение показателей концентрации тестостерона и эпитестостерона, в частности, путем применения эпитестостерона <*> и бромантана.
<*> Если концентрация эпитестостерона в моче превышает 200 нанограммов на миллилитр, проводится исследование в соответствии с пунктом I.C.(1).
Не имеет решающего значения, привело или нет к предполагаемому результату применение того или иного запрещенного вещества или метода. Само применение либо попытка применения такого вещества или метода рассматривается как нарушение.
По согласованию с международными спортивными федерациями и соответствующими властями могут проводиться тесты на применение этанола.
Результаты могут повлечь за собой применение санкций.
По согласованию с международными спортивными федерациями и соответствующими властями могут проводиться тесты на каннабиноиды (например, марихуана и гашиш).
Результаты могут повлечь за собой применение санкций.
C. Местные анестезирующие средства
Разрешено использование для инъекций местных анестезирующих средств при соблюдении следующих условий:
a) разрешено применять бупивакаин, лидокаин, мепивакаин, прокаин и т.д., но не кокаин. Сосудосуживающие средства (например, адреналин) могут использоваться вместе с местными анестетиками;
b) разрешено делать только местные или внутрисуставные инъекции;
c) только при наличии медицинских показаний.
По согласованию с международными спортивными федерациями и компетентными органами может быть признано необходимым сообщать о надлежащем применении местных анестезирующих средств, кроме применения для стоматологического лечения. Заключение в письменной форме с указанием диагноза, дозы и способа применения должно быть передано в медицинскую комиссию до начала соревнований или сразу после инъекции, если она была сделана во время соревнований.
Применение кортикостероидов запрещено, кроме следующих случаев:
a) местное применение (анальное, ушное, дерматологическое, носовое или офтальмологическое), но не ректальное;
c) путем местных или внутрисуставных инъекций.
Введено правило, в соответствии с которым необходимо сообщать о тех случаях, когда спортсменам во время соревнований требуется применение кортикостероидов путем ингаляций в качестве антиастматического средства. Каждый врач команды, намеревающийся назначить спортсмену кортикостероиды путем местной или внутрисуставной инъекции или в виде ингаляций, должен представить письменное уведомление соответствующему медицинскому органу до начала соревнований.
алпренолол, атенолол, ацебутолол, лабетолол, метопролол, надолол, окспренолол, пропранолол, соталол и относящиеся к этому классу вещества.
В соответствии с правилами международных спортивных федераций тесты осуществляются в отдельных видах спорта, по усмотрению соответствующих компетентных органов. Результаты могут повлечь за собой применение санкций.
| Вещества | Применение запрещено | Применение разрешено при условии сообщения о применении | Разрешены без обязательного сообщения о применении |
|---|---|---|---|
| некоторые бета-агонисты <*> | - перорально — системные инъекции | - ингаляции | |
| кортикостероиды | - перорально — системные инъекции — ректально | - ингаляции — местные инъекции — внутрисуставные инъекции | - местное применение (анальное, оториноларингологическое, дерматологическое, офтальмологическое) |
| местные обезболивающие средства <**> | - системные инъекции | - стоматологическое лечение — местные инъекции <***> - внутрисуставные инъекции <***> |
<*> салбутамол, салметерол, тербуталин; все остальные бета-агонисты запрещены;
<**> кроме кокаина, который запрещен;
<***> по соглашению с международными спортивными федерациями в отдельных видах спорта может требоваться сообщение о применении.
катин > 5 микрограммов на миллилитр метилэфедрин > 5 микрограммов на миллилитр морфин > 1 микрограмма на миллилитр псевдоэфедрин > 10 микрограммов на миллилитр соотношение T/E > 6 фенилпропаноламин > 10 микрограммов на миллилитр эпитестостерон > 200 нанограммов на миллилитр эфедрин > 5 микрограммов на миллилитр
Данный список запрещенных веществ не является исчерпывающим. Многие вещества, не упомянутые в нем, являются запрещенными, поскольку принадлежат к «относящимся к этому классу веществам».
Всем спортсменам настоятельно рекомендуется применять лекарственные средства только по назначению врача и удостовериться, что они содержат только вещества, разрешенные (медицинской комиссией МОК или) компетентными органами.
В случае, когда спортсмен должен пройти антидопинговый контроль, в официальном протоколе такого контроля должны быть обязательно указаны все лекарственные средства и препараты, которые принимались им или были введены ему в течение 3-х предшествующих дней.
аминептин, амифеназол, амфепрамон, амфетамин, бамбутерол, бромантан, гептаминол, карфедон, катин, кокаин, кофеин, кропропамид, кротетамид, мезокарб, метамфетамин, метилендиоксиамфетамин, метилфенидат, метилэфедрин, метоксифенамин, мефенорекс, никетамид, мефентермин, норфенфлурамин, парагидроксиамфетамин, пемолин, пентилентетразол. пипрадол, пролинтан, пропилекседрин, псевдоэфедрин, репротерол, салбутамол, салметерол, селегилин, стрихнин, тербуталин, фендиметразин, фенетилин, фенилпропаноламин, фенкамфамин, фентермин, фенфлурамин, фоледрин, формотерол, этамиван, этиламфетамин, этилефрин, эфедрин.
декстроморамид, диаморфин (героин), гидрокодон, метадон, морфин, пентазоцин, петидин.
андростенедион, бамбутерол, болденон, гестринон, даназол, дегидрохлорметилтестостерон, дегидрозпиандростерон (DHEA), дигидротестостерон, дростанолон, кленбутерол, клостебол, местеролон, метандиенон, метандриол, метенолон, метилтестостерон, миболерон, нандролон, норетандролон, оксандролон, оксиместерон, оксиметолон, репротерол, салбутамол, салметерол, станозолол, тербуталин, тестостерон, тренболон, фенотерол, флуоксиместерон, формотерол, формеболон.
ацетазоламид, бендрофлуметиазид, буметанид, гидрохлортиазид, индапамид, канренон, маннитол, мерсалил, спиронолактон, триамтерен, фуросемид, хлорталидон, этакриновая кислота.
бромантан, эпитестостерон, пробенецид.
ACTH, эритропоэтин (EPO), hCG, hGH.
ацебутолол, алпренолол, атенолол, бетаксолол, бисопролол, бунолол, лабетолол, метопролол, надодол, окспренолол, пропранолол, соталол.
The member States of the Council of Europe, the other States party to the European Cultural Convention, and other States, signatory hereto,
Considering that the aim of the Council of Europe is to achieve a greater unity between its members for the purpose of safeguarding and realising the ideals and principles which are their common heritage and of facilitating their economic and social progress;
Conscious that sport should play an important role in the protection of health, in moral and physical education and in promoting international understanding;
Concerned by the growing use of doping agents and methods by sportsmen and sportswomen throughout sport and the consequences thereof for the health of participants and the future of sport;
Mindful that this problem puts at risk the ethical principles and educational values embodied in the Olympic Charter, in the International Charter for Sport and Physical Education of Unesco and in Resolution (76) 41 of the Committee of Ministers of the Council of Europe, known as the «European Sport for All Charter»;
Bearing in mind the anti-doping regulations, policies and declarations adopted by the international sports organisations;
Aware that public authorities and the voluntary sports organisations have complementary responsibilities to combat doping in sport, notably to ensure the proper conduct, on the basis of the principle of fair play, of sports events and to protect the health of those that take part in them;
Recognising that these authorities and organisations must work together for these purposes at all appropriate levels;
Recalling the resolutions on doping adopted by the Conference of European Ministers responsible for Sport, and in particular Resolution No. 1 adopted at the 6th Conference at Reykjavik in 1989;
Recalling that the Committee of Ministers of the Council of Europe has already adopted Resolution (67) 12 on the doping of athletes, Recommendation No. R (79) 8 on doping in sport, Recommendation No. R (84) 19 on the «European Anti-Doping Charter for Sport», and Recommendation No. R (88) 12 on the institution of doping controls without warning outside competitions;
Recalling Recommendation No. 5 on doping adopted by the 2nd International Conference of Ministers and Senior Officials responsible for Sport and Physical Education organised by Unesco at Moscow (1988);
Determined however to take further and stronger co-operative action aimed at the reduction and eventual elimination of doping in sport using as a basis the ethical values and practical measures contained in those instruments,
The Parties, with a view to the reduction and eventual elimination of doping in sport, undertake, within the limits of their respective constitutional provisions, to take the steps necessary to apply the provisions of this Convention.
1. For the purposes of this Convention:
a. «doping in sport» means the administration to sportsmen or sportswomen, or the use by them, of pharmacological classes of doping agents or doping methods;
b. «pharmacological classes of doping agents or doping methods» means, subject to paragraph 2 below, those classes of doping agents or doping methods banned by the relevant international sports organisations and appearing in lists that have been approved by the Monitoring Group under the terms of Article 11.1.b;
c. «sportsmen and sportswomen» means those persons who participate regularly in organised sports activities.
2. Until such time as a list of banned pharmacological classes of doping agents and doping methods is approved by the Monitoring Group under the terms of Article 11.1.b, the reference list in the appendix to this Convention shall apply.
1. The Parties shall co-ordinate the policies and actions of their government departments and other public agencies concerned with combating doping in sport.
2. They shall ensure that there is practical application of this Convention, and in particular that the requirements under Article 7 are met, by entrusting, where appropriate, the implementation of some of the provisions of this Convention to a designated governmental or non-governmental sports authority or to a sports organisation.
1. The Parties shall adopt, where appropriate, legislation, regulations or administrative measures to restrict the availability (including provisions to control movement, possession, importation, distribution and sale) as well as the use in sport of banned doping agents and doping methods and, in particular, anabolic steroids.
2. To this end, the Parties or, where appropriate, the relevant non-governmental organisations shall make it a criterion for the grant of public subsidies to sports organisations that they effectively apply antidoping regulations.
3. Furthermore, the Parties shall:
a. assist their sports organisations to finance doping controls and analyses, either by direct subsidies or grants, or by recognising the costs of such controls and analyses when determining the overall subsidies or grants to be awarded to those organisations;
b. take appropriate steps to withhold the grant of subsidies from public funds, for training purposes, to individual sportsmen and sportswomen who have been suspended following a doping offence in sport, during the period of their suspension;
c. encourage and, where appropriate, facilitate the carrying out by their sports organisations of the doping controls required by the competent international sports organisations whether during or outside competitions; and
d. encourage and facilitate the negotiation by sports organisations of agreements permitting their members to be tested by duly authorised doping control teams in other countries.
4. Parties reserve the right to adopt anti-doping regulations and to organise doping controls on their own initiative and on their own responsibility, provided that they are compatible with the relevant principles of this Convention.
a. either to establish or facilitate the establishment on its territory of one or more doping control laboratories suitable for consideration for accreditation under the criteria adopted by the relevant international sports organisations and approved by the Monitoring Group under the terms of Article 11.1.b; or
b. to assist its sports organisations to gain access to such a laboratory on the territory of another Party.
2. These laboratories shall be encouraged to:
a. take appropriate action to employ and retain, train and retrain qualified staff;
b. undertake appropriate programmes of research and development into doping agents and methods used, or thought to be used, for the purposes of doping in sport and into analytical biochemistry and pharmacology with a view to obtaining a better understanding of the effects of various substances upon the human body and their consequences for athletic performance;
c. publish and circulate promptly new data from their research.
1. The Parties undertake to devise and implement, where appropriate in co-operation with the sports organisations concerned and the mass media, educational programmes and information campaigns emphasising the dangers to health inherent in doping and its harm to the ethical values of sport. Such programmes and campaigns shall be directed at both young people in schools and sports clubs and their parents and at adult sportsmen and sportswomen, sports officials, coaches and trainers. For those involved in medicine, such educational programmes will emphasise respect for medical ethics.
2. The Parties undertake to encourage and promote research, in co-operation with the regional, national and international sports organisations concerned, into ways and means of devising scientifically-based physiological and psychological training programmes that respect the integrity of the human person.
1. The Parties undertake to encourage their sports organisations and through them the international sports organisations to formulate and apply all appropriate measures, falling within their competence, against doping in sport.
2. To this end, they shall encourage their sports organisations to clarify and harmonise their respective rights, obligations and duties, in particular by harmonising their:
a. anti-doping regulations on the basis of the regulations agreed by the relevant international sports organisations;
b. lists of banned pharmacological classes of doping agents and banned doping methods on the basis of the lists agreed by the relevant international sports organisations;
d. disciplinary procedures, applying agreed international principles of natural justice and ensuring respect for the fundamental rights of suspected sportsmen and sportswomen; these principles will include:
i. the reporting and disciplinary bodies to be distinct from one another;
ii. the right of such persons to a fair hearing and to be assisted or represented;
iii. clear and enforceable provisions for appealing against any judgment made;
e. procedures for the imposition of effective penalties for officials, doctors, veterinary doctors, coaches, physiotherapists and other officials or accessories associated with infringements of the antidoping regulations by sportsmen and sportswomen;
f. procedures for the mutual recognition of suspensions and other penalties imposed by other sports organisations in the same or other countries.
3. Moreover, the Parties shall encourage their sports organisations:
a. introduce, on an effective scale, doping controls not only at, but also without advance warning at any appropriate time outside, competitions, such controls to be conducted in a way which is equitable for all sportsmen and sportswomen and which includes testing and retesting of persons selected, where appropriate, on a random basis;
b. to negotiate agreements with sports organisations of other countries permitting a sportsman or sportswoman training in another country to be tested by a duly authorised doping control team of that country;
c. to clarify and harmonise regulations on eligibility to take part in sports events which will include anti-doping criteria;
d. to promote active participation by sportsmen and sportswomen themselves in the anti-doping work of international sports organisations;
e. to make full and efficient use of the facilities available for doping analysis at the laboratories provided for by Article 5, both during and outside sports competitions;
f. to study scientific training methods and to devise guidelines to protect sportsmen and sportswomen of all ages, appropriate for each sport.
1. The Parties shall co-operate closely on the matters covered by this Convention and shall encourage similar co-operation amongst their sports organisations.
a. to encourage their sports organisations to operate in a manner that promotes application of the provisions of this Convention within all the appropriate international sports organisations to which they are affiliated, including the refusal to ratify claims for world or regional records unless accompanied by an authenticated negative doping control report;
b. to promote co-operation between the staffs of their doping control laboratories established or operating in pursuance of Article 5; and
c. to initiate bilateral and multilateral co-operation between their appropriate agencies, authorities and organisations in order to achieve, at the international level as well, the purposes set out in Article 4.1.
3. The Parties with laboratories established or operating in pursuance of Article 5 undertake to assist other Parties to enable them to acquire the experience, skills and techniques necessary to establish their own laboratories.
Each Party shall forward to the Secretary General of the Council of Europe, in one of the official languages of the Council of Europe, all relevant information concerning legislative and other measures taken by it for the purpose of complying with the terms of this Convention.
1. For the purposes of this Convention, a Monitoring Group is hereby set up.
2. Any Party may be represented on the Monitoring Group by one or more delegates. Each Party shall have one vote.
3. Any State mentioned in Article 14.1 which is not a Party to this Convention may be represented on the Monitoring Group by an observer.
4. The Monitoring Group may, by unanimous decision, invite any non-member State of the Council of Europe which is not a Party to the Convention and any sports or other professional organisation concerned to be represented by an observer at one or more of its meetings.
5. The Monitoring Group shall be convened by the Secretary General. Its First meeting shall be held as soon as reasonably practicable, and in any case within one year after the date of the entry into force of the Convention. It shall subsequently meet whenever necessary, on the initiative of the Secretary General or a Party.
6. A majority of the Parties shall constitute a quorum for holding a meeting of the Monitoring Group.
7. The Monitoring Group shall meet in private.
8. Subject to the provisions of this Convention, the Monitoring Group shall draw up and adopt by consensus its own Rules of Procedure.
1. The Monitoring Group shall monitor the application of this Convention. It may in particular:
a. keep under review the provisions of this Convention and examine any modifications necessary;
b. approve the list, and any revision thereto, of pharmacological classes of doping agents and doping methods banned by the relevant international sports organisations, referred to in Articles 2.1 and 2.2, and the criteria for accreditation of laboratories, and any revision thereto, adopted by the said organisations, referred to in Article 5.1.a, and fix the date for the relevant decisions to enter into force;
c. hold consultations with relevant sports organisations;
d. make recommendations to the Parties concerning measures to be taken for the purposes of this Convention;
e. recommend the appropriate measures to keep relevant international organisations and the public informed about the activities undertaken within the framework of this Convention;
f. make recommendations to the Committee of Ministers concerning non-member States of the Council of Europe to be invited to accede to this Convention;
g. make any proposal for improving the effectiveness of this Convention.
2. In order to discharge its functions, the Monitoring Group may, on its own initiative, arrange for meetings of groups of experts.
After each meeting, the Monitoring Group shall forward to the Committee of Ministers of the Council of Europe a report on its work and on the functioning of the Convention.
1. Amendments to the Articles of this Convention may be proposed by a Party, the Committee of Ministers of the Council of Europe or the Monitoring Group.
2. Any proposal for amendment shall be communicated by the Secretary General of the Council of Europe to the States mentioned in Article 14 and to every State which has acceded to or has been invited to accede to this Convention in accordance with the provisions of Article 16.
3. Any amendment proposed by a Party or the Committee of Ministers shall be communicated to the Monitoring Group at least two months before the meeting at which it is to be considered. The Monitoring Group shall submit to the Committee of Ministers its opinion on the proposed amendment, where appropriate after consultation with the relevant sports organisations.
4. The Committee of Ministers shall consider the proposed amendment and any opinion submitted by the Monitoring Group and may adopt the amendment.
5. The text of any amendment adopted by the Committee of Ministers in accordance with paragraph 4 of this Article shall be forwarded to the Parties for acceptance.
6. Any amendment adopted in accordance with paragraph 4 of this Article shall come into force on the first day of the month following the expiration of a period of one month after all Parties have informed the Secretary General of their acceptance thereof.
1. This Convention shall be open for signature by member States of the Council of Europe, other States party to the European Cultural Convention and non-member States which have participated in the elaboration of this Convention, which may express their consent to be bound by:
a. signature without reservation as to ratification, acceptance or approval, or
b. signature subject to ratification, acceptance or approval, followed by ratification, acceptance or approval.
2. Instruments of ratification, acceptance or approval shall be desposited with the Secretary General of the Council of Europe.
1. The Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date on which Five States, including at least four member States of the Council of Europe, have expressed their consent to be bound by the Convention in accordance with the provisions of Article 14.
2. In respect of any signatory State which subsequently expresses its consent to be bound by it, the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of signature or of the deposit of the instrument of ratification, acceptance or approval.
1. After the entry into force of this Convention, the Committee of Ministers of the Council of Europe, after consulting the Parties, may invite to accede to the Convention any non-member State by a decision taken by the majority provided for in Article 20.d of the Statute of the Council of Europe and by the unanimous vote of the representatives of the Contracting States entitled to sit on the Committee.
2. In respect of any acceding State, the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of the deposit of the instrument of accession with the Secretary General of the Council of Europe.
1. Any State may, at the time of signature or when depositing its instrument of ratification, acceptance, approval or accession, specify the territory or territories to which this Convention shall apply.
2. Any State may, at any later date, by a declaration addressed to the Secretary General of the Council of Europe, extend the application of this Convention to any other territory specified in the declaration. In respect of such territory the Convention shall enter into force on the first day of the month following the expiration of a period of one month after the date of receipt of such declaration by the Secretary General.
3. Any declaration made under the two preceding paragraphs may, in respect of any territory mentioned in such declaration, be withdrawn by a notification addressed to the Secretary General. Such withdrawal shall become effective on the first day of the month following the expiration of a period of six months after the date of receipt of the notification by the Secretary General.
1. Any Party may, at any time, denounce this Convention by means of a notification addressed to the Secretary General of the Council of Europe.
2. Such denunciation shall become effective on the first day of the month following the expiration of a period of six months after the date of receipt of the notification by the Secretary General.
The Secretary General of the Council of Europe shall notify the Parties, the other member States of the Council of Europe, the other States party to the European Cultural Convention, the non-member States which have participated in the elaboration of this Convention and any State which has acceded or has been invited to accede to it of:
a. any signature in accordance with Article 14;
b. the deposit of any instrument of ratification, acceptance, approval or accession in accordance with Article 14 or 16;
c. any date of entry into force of this Convention in accordance with Articles 15 and 16;
d. any information forwarded under the provisions of Article 9;
e. any report prepared in pursuance of the provisions of Article 12;
f. any proposal for amendment or any amendment adopted in accordance with Article 13 and the date on which the amendment comes into force;
g. any declaration made under the provisions of Article 17;
h. any notification made under the provisions of Article 18 and the date on which the denunciation takes effect;
i. any other act, notification or communication relating to this Convention.
In witness whereof the undersigned, being duly authorised thereto, have signed this Convention.
Done at Strasbourg, the 16th day of November 1989, in English and in French, both texts being equally authentic, in a single copy which shall be deposited in the archives of the Council of Europe. The Secretary General of the Council of Europe shall transmit certified copies to each member State of the Council of Europe, to the other States party to the European Cultural Convention, to the non-member States which have participated in the elaboration of this Convention and to any State invited to accede to it.
LIST OF PROHIBITED CLASSES OF SUBSTANCES AND PROHIBITED METHODS <*>
E. Peptide and glycoprotein hormones and analogues
B. Pharmacological, chemical and physical manipulation
<*> Status as of 15 March 1998. The appendix is regularly revised by the Monitoring Group on the basis of the anti-doping list of the International Olympic Committee (previously amended on 1 September 1990, on 24 January 1992, on 1 August 1993, on 1 July 1996 and on 1 July 1997.)
Prohibited substances fall into the following classes of substances:
E. Peptide and glycoprotein hormones and analogues
All substances belonging to the prohibited classes cannot be used even if they are not listed as examples. For this reason, the term «and related substances» is introduced. This term describes drugs that are related to the class by their pharmacological action and / or chemical structure.
Prohibited substances in class (A) include the following examples: amineptine, amiphenazole, amphetamines, bromantan, caffeine <>, carphedon, cocaine, ephedrines <>, fencamfamin, mesocarb, pentylentetrazol, pipradol, salbutamol <>, salmeterol <>, terbutaline <>, and related substances.
<*> For caffeine the definition of a positive result depends on the concentration of caffeine in the urine. The concentration in urine may not exceed 12 micrograms per millilitre.
<**> For ephedrine, cathine and methylephedrine, the definition of a positive is 5 micrograms per millilitre of urine. For phenylpropanolamine and pseudoephedrine the definition of a positive is 10 micrograms per millilitre. If more than one of these substances is present, the quantities should be added, and, if the sum exceeds 10 micrograms per millilitre the sample shall be considered positive.
<***> Permitted by inhaler only when their use is previously certified in writing by a respiratory or team physician to the relevant medical authority.
note: All imidazole preparations are acceptable for topical use, e.g. oxymetazoline. Vasoconstrictors (e.g. adrenaline) may be administered with local anaesthetic agents. Topical preparations (e.g. nasal, ophtalmological) of phenylephrine are permitted.
Prohibited substances in class (B) include the following examples:
dextromoramide, diamorphine (heroin), methadone, morphine, pentazocine, pethidine and related substances.
note: codeine, dextromethorphan, dexiropropoxyphene, dihydrocodeine, diphenoxylate, ethylmorphine, pholcodine and propoxyphene are permitted.
Prohibited substances in class (C) include the following examples:
1. Anabolic androgenic steroids
androstenedione, clostebol, dehydroepiandrosterone (DHEA), fluoxymesterone, metandienone, metenolone, nandrolone, oxandrolone, stanozolol, testosterone <*>, and related substances.
<*> The presence of a testosterone (T) to epitestosterone (E) ratio greater than six (6) to one (1) in the urine of a competitor constitutes an offence unless there is evidence that this ratio is due to a physiological or pathological condition, e.g. low epitestosterone excretion, androgen producing tumour, enzyme deficiencies.
In the case of T/E higher than 6, it is mandatory that the relevant medical authority conduct an investigation before the sample is declared positive. A full report will be written and will include a review of previous tests, subsequent tests and any results of endocrine investigations. In the event that previous tests are not available, the athlete should be tested unannounced at least once per month for three months. The results of these investigations should be included in the report. Failure to cooperate in the investigations will result in declaring the sample positive.
When administered systemically, beta-2 agonists may have powerful anabolic effects.
Clenbuterol, fenoterol, salbutamol, salmeterol, terbutaline and related substances.
Prohibited substances in class (D) include the following examples:
acetazolamide, bumetanide, chlorthalidone, ethacrynic acid, furosemide, hydrochlorothiazide, mannitol <*>, mersalyl, spironolactone, triamterene, and related substances.
<*> Prohibited by intravenous injection.
E. Peptide and glycoprotein hormones and analogues
Prohibited substances in class (E) include the following examples:
1. Chorioilic Gonadotrophin (hCG — human chorionic gonadotrophin);
3. Growth hormone (hGH — somatotrophin):
All the respective releasing factors (and their analogues) of the above-mentioned substances are also prohibited.
The following procedures are prohibited:
Blood doping is the administration of blood, red blood cells and related blood products to an athlete. This procedure may be preceded by withdrawal of blood from the athlete who continues to train in this blood depleted state.
Pharmaceutical, chemical and physical manipulation
Pharmaceutical, chemical and physical manipulation is the use of substances and of methods which alter, attempt to alter or may reasonably be expected to alter the integrity and validity of urine samples used in doping controls, including, without limitation, catheterisation, urine substitution and or tampering, inhibition of renal excretion such as by probenecid and related compounds and alterations of testosterone and epitestosterone measurements such as epitestosterone <*> or bromantan administration.
<*> An epitestosterone concentration in the urine in excess of 200 nanograms per millilitre will have to be investigated by studies as in Article I.C (I).
The success or failure of the use of a prohibited substance or method is not material. It is sufficient that the said substance or procedure was used or attempted for the infraction to be considered as consummated.
In agreement with the International Sports Federations and the responsible authorities, tests may be conducted for ethanol. The results may lead to sanctions.
In agreement with the International Sports Federations and the responsible authorities, tests may be conducted for cannabinoids (e.g. Marijuana, Hashish). The results may lead to sanctions.
Injectable local anaesthetics are permitted under the following conditions:
a) bupivacaine, lidocaine, mepivacaine, procaine, etc. can be used but not cocaine. Vasoconstrictor agents (e.g. adrenaline) may be used in conjunction with local anaesthetics.
b) only local or intra-articular injections may be administered.
c) only when medically justified.
In agreement with International Sports Federations and the responsible authorities, notification of the permitted use may be necessary except for dental application. The details including diagnosis, dose and route of administration must be submitted prior to the competition or, if administered during the competition, immediately after injection, in writing to the relevant medical authority.
The use of corticosteroids is banned except:
a) for topical use (anal, aural, dermatological, nasal and ophtalmological) but not rectal;
c) by intra-articular or local injection.
Mandatory reporting of athletes requiring corticosteroids by inhalation for the treatment of asthma during competitions lias been introduced. Any team doctor wishing to administer corticosteroids by inhalation or by local or intra-articular injection to a competitor must give written notification prior to the competition to the relevant medical authority.
Some examples of beta-blockers are:
acebutolol, alprenolol, atenolol, labetalol, metoprolol, nadolol, oxprenolol, propranolol, sotalol and related substances.
In agreement with the rules of the International Sports Federations, tests will be conducted in some sports, at the discretion of the responsible authorities. The results may lead to sanctions.
| SUBSTANCES | PROHIBITED | AUTHORISED WITH NOTIFICATION | AUTHORISED WITHOUT NOTIFICATION |
|---|---|---|---|
| Selected beta-agonists <*> | - Oral — Systemic injections | - Inhalatory | |
| Corticosteroids | - Oral — Systemic injections — Rectal | - Inhalatory — Local injections — Intraarticular injections | - Topical (anal, aural, dermatological, nasal, ophtalmological) |
| Local anaesthetics <**> | - Systemic injections | - Dental — Local injections <> — Intraarticular injections <> |
<*> salbutamol, salmeterol, terbutaline; all others beta-agonists are prohibited.
<**> except cocaine, which is prohibited.
<***> in agreement with some International Sports Federations, notification may be necessary in some sports.
cathine >5 micrograms / millilitre ephedrine >5 micrograms / millilitre epitestosterone >200 nanograms / millilitre methylephedrine >5 micrograms / millilitre morphine >1 microgram / millilitre phenylpropanolamine >10 micrograms / millilitre pseudoephedrine >10 micrograms / millilitre T/E ratio >6
This is not an exhaustive list of prohibited substances. Many substances that do not appear on this list are prohibited under the term «and related substances».
All athletes are strongly advised only to take medicines which are prescribed by a medical doctor and to ensure that they contain only drugs that are not prohibited by [the I.O.C. Medical Commission or] the responsible authorities.
Whenever an athlete is required to undergo a doping control it is essential that all medications and drugs taken or administered in the previous three days are declared on the doping control official record.
amineptine, amfepramone, amiphenazole, amphetamine, bambuterol, bromantan, caffeine, carphedon, cathine, cocaine, cropropamide, crotethamide, ephedrine, etamivan, etilamphetamine, etilefrine, fencamfamine, fenetylline, fenfluramine, formoterol, heptaminol, methylendioxyamphetamine, mefenorex, mephentermine, mesocarb, methamphetamine, methoxyphenamine, methylephedrine, methylphenidate, nikethamide, norfenfluramine, parahydroxyamphetamine, pemoline, pentylentetrazol, phendimetrazine, phentermine, phenylpropanolamine, pholedrine, pipradol, prolintane, propylhexedrine, pseudoephedrine, reproterol, salbutamol, salmeterol, selegiline, strychnine, terbutaline,
dextromoramide, diamorphine (heroin), hydrocodone, methadone, morphine, pentazocine, pethidine.
androstenedione, bambuterol, boldenone, clenbuterol, clostebol, danazol, dehydrochlor methyltestosterone, dehydroepiandrosterone (DHEA), dihydrotestosterone, drostanolone, fenoterol, formoterol, nuoxymesterone, formebolone, gestrinone, mesterolone, metandienone, metenolone, methandriol, methyltestosterone, mibolerone, nandrolone, norethandrolone, oxandrolone, oxymesterone, oxymetholone, reproterol, salbutamol, salmeterol, stanozolol, terbutaline, testosterone, trenbolone.
acetazolamide, bendroflumethiazide, bumetanide, canrenone, chlortalidone, ethacrynic acid, furosemide, hydrochlorothiazide, indaparnide, mannitol, mersalyl, spironolactone, triamterene.
bromantan, epitestosterone, probenecid.
ACTH, erythropoietin (EPO), hCG, hGH.
acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, labetalol, metoprolol, nadodol, oxprenolol, propranolol, sotalol.
Переход между статьями: Ctrl + ← / →